Close Association of Herpes Zoster Reactivation and Systemic Lupus Erythematosus (SLE) Diagnosis: Case-Control Study of Patients with SLE or Noninflammatory Musculoskeletal Disorders

Journal of Rheumatology

Volumn 31, Issue 2, 2004, Pages 274-279

  Pope, Janet E ^a,b,c   Krizova, Adriana ^a   Ouimet, Janine M ^a   Goodwin, Jodi L ^a   Laskin, Matthew D ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Dept of Med Epidemiol/Biostatist ^*  (Canada)

^c ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

Infections; Systemic lupus erythematosus; Vaccinations; Zoster

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; STEROID;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; EAR INFECTION; EYE INFECTION; FEMALE; FEVER; FIBROMYALGIA; HEPATITIS A; HEPATITIS B; HEPATITIS C; HERPES ZOSTER; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; JOINT INJURY; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; OSTEOARTHRITIS; PHARYNGITIS; POSTOPERATIVE INFECTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RASH; RESPIRATORY TRACT INFECTION; RHEUMATIC FEVER; STREPTOCOCCUS INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TENDINITIS; TRAVEL; TUBERCULIN TEST; URINARY TRACT INFECTION; VIRUS INFECTION; VIRUS REACTIVATION; VOMITING;

CASE-CONTROL STUDIES; FEMALE; HERPES ZOSTER; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MUSCULOSKELETAL DISEASES; QUESTIONNAIRES; RECURRENCE; RISK FACTORS; VACCINATION;

EID: 0742305107     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Stratta P, Canavese C, Ciccone G, et al. Correlation between cytomegalovirus infection and Raynaud's phenomenon in lupus nephritis. Nephron 1999;82:145-54.
2. Rider JR, Ollier WE, Lock RJ, Brookes ST, Pamphilon DH. Human cytomegalovirus infection and systemic lupus erythematosus. Clin Exp Rheumatol 1997;15:405-9.
3. James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997;100:3019-26.
4. James JA, Neas BR, Moser KL, et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 2001;44:1122-6.
5. Lau CS, Yuen KY, Chan KH, Wong RW, Lack of evidence of active lytic replication of Epstein-Barr and cytomegaloviruses in patients with systemic lupus erythematosus. Chin Med J (Engl) 1998;111:660-5.
6. Haaheim LR, Halse AK, Kvakestad R, Stem B, Normann O, Jonsson R. Serum antibodies from patients with primary Sjogren's syndrome and systemic lupus erythematosus recognize multiple epitopes on the La(SS-B) autoantigen resembling viral protein sequences. Scand J Immunol 1996;43:115-21.
7. Yamauchi Y, Nagasawa K, Tada Y, et al. Herpes zoster in connective tissue diseases: I. Association with systemic lupus erythematosus and its immunological abnormalities. Kansenshogaku Zasshi 1991;65:851-6.
8. Nagasawa K, Yamauchi Y, Tada Y, Kusaba T, Niho Y, Yoshikawa H. High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis. Ann Rheum Dis 1990;49:630-3.
9. Moutsopoulos HM, Gallagher JD, Decker JL, Steinberg AD. Herpes zoster in patients with systemic lupus erythematosus. Arthritis Rheum 1978;21:789-802.
10. Kahl LE. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome. J Rheumatol 1994;21:84-6.
11. Strom BL, Reidenberg MM, West S, Snyder ES, Freundlich B, Stolley PD. Shingles, allergies, family medical history, oral contraceptives and other potential risk factors for systemic lupus erythematosus. Am J Epidemiol 1994;140:632-42.
12. Manzi S, Kuller LH, Kutzer J, et al. Herpes zoster in systemic lupus erythematosus. J Rheumatol 1995;22:1254-8.
13. Moga I, Formiga F, Canet R, Pac M, Mitjavila F, Pujol R. Herpes zoster virus infection in patients with systemic lupus erythematosus. Rev Clin Esp 1995;195:530-3.
14. Ishikawa O, Abe M, Miyachi Y. Herpes zoster in Japanese patients with systemic lupus erythematosus. Clin Exp Dermatol 1999;24:327-8.
15. Pons VG, Reinertsen JL, Steinberg AD, Dolin R. Decreased cell-mediated cytotoxicity against virus-infected cells in systemic lupus erythematosus. J Med Virol 1979;4:15-23.
16. Finielz P, Lam-Kam-Sang LF, Guiserix J. Systemic lupus erythematosus and thrombocytopenic purpura in two members of the same family following hepatitis B vaccine. Nephrol Dial Transplant 1998;13:2420-1.
17. Guiserix J. Systemic lupus erythematosus following hepatitis B vaccine [letter]. Nephron 1996;74:441.
18. Grezard P, Chefai M, Philippot V, Perrot H, Faisant M. Cutaneous lupus erythematosus and buccal aphthosis after hepatitis B vaccination in a 6-year-old child. Ann Dermatol Venereol 1996;123:657-9.
19. Older SA, Battafarano DF, Enzenauer RJ, Krieg AM. Can immunization precipitate connective tissue disease? Report of five cases of systemic lupus erythematosus and review of the literature. Semin Arthritis Rheum 1999;29:131-9.
20. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
21. Zonana-Nacach A, Camargo-Coronel A, Yanez P, Sanchez L, Jimenez-Balderas FJ, Fraga A. Infections in outpatients with systemic lupus erythematosus: a prospective study. Lupus 2001;10:505-10.
22. Nived O, Sturfelt G, Wollheim F. Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group. QJM 1985;55:271-87.
23. Hogenesch H, Azcona-Olivera J, Scott-Moncrieff C, Snyder PW, Glickman LT. Vaccine-induced autoimmunity in the dog. Adv Vet Med 1999;41:733-47.
24. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity - 'vaccinosis': a dangerous liaison? J Autoimmun 2000;14:1-10.
25. Maillefert JF, Sibilia J, Toussirot E, et al. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology Oxford 1999;38:978-83.
26. Dobson S, Scheifele D, Bell A. Assessment of a universal, school-based hepatitis B vaccination program. JAMA 1995;274:1242-3.
27. Dentico P, Buongiomo R, Volpe A, Zavoianni A, Pastore G, Schiraldi O. Long-term immunogenicity safety and efficacy of a recombinant hepatitis B vaccine in healthy adults. Eur J Epidemiol 1992;8:650-5.
28. McMahon BJ, Helminiak C, Wainwright RB, Bulkow L, Trimble BA, Wainwright K. Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. Am J Med 1995;98:595-6.
29. Chassagne P, Mejjad O, Gourmelen O, Moore N, Le Loet X, Deshayes P. Exacerbation of systemic lupus erythematosus during human parvovirus B 19 infection. Br J Rheumatol 1993;32:158-9.
30. Fawaz-Estrup F. Human parvovirus infection: rheumatic manifestations, angioedema, C1 esterase inhibitor deficiency, ANA positivity, and possible onset of systemic lupus erythematosus. J Rheumatol 1996;23:1180-5.
31. Kalish RA, Knopf AN, Gary GW, Canoso JJ. Lupus-like presentation of human parvovirus B19 infection. J Rheumatol 1992;19:169-71.
32. Glickstein SL. Lupus-like presentation of human parvovirus B19 infection [letter]. J Rheumatol 1993;20:1253.
33. Vigeant P, Menard HA, Boire G. Chronic modulation of the autoimmune response following parvovirus B 19 infection. J Rheumatol 1994;21:1165-7.
34. Moore TL, Bandlamudi R, Alam SM, Nesher G. Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population. Semin Arthritis Rheum 1999;28:314-8.
35. Meyer O, Kahn MF, Grossin M, et al. Parvovirus B19 infection can induce histiocytic necrotizing lymphadenitis (Kikuchi's disease) associated with systemic lupus erythematosus. Lupus 1991;137-41.